Literature DB >> 23105685

A comparative study on the effects of diet and exercise, metformin and metformin+pioglitazone treatment on NIDDM patients.

K T Augusti1, N P Sunil, Andrews Abraham, Sajimon Thomas, Varghese Chemmanam.   

Abstract

A comparative study on two groups of newly diagnosed nonobese and obese NIDDM patients who were 15 in each group and treated by diet cum exercise and metfromin monotherapy respectively and a third group of 15 obese NIDDM patients whose hyperglycemia was not first controlled by a combination therapy of metformin and sulfonylurea and therefore changed over to a different combination therapy of metformin and ploglitazone, was carried out before and after a period of three months treatment. The mild hyperglycemia in the 1(st) group and the moderate or severe hyperglycemia with accompanied disorders of serum enzymes such as AST, ALT, GGT and the level of HBA(10) observed with 2(nd) and 3(rd) groups of obese NIDDM patients were significantly ameliorated by the respective mode of treatments. Here the efficacies of the three types of treatment are substantiated and further it specifically depicts the success with the choice of combination therapy with metformin and pioglitazone in the third group of obese diabetics.

Entities:  

Keywords:  Diet cum exercise; Enzymes; FBS; HbA10; Metformin; NIDDM patients; Pioglitazone

Year:  2007        PMID: 23105685      PMCID: PMC3453793          DOI: 10.1007/BF02913316

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  17 in total

1.  Exercise and decreased risk of NIDDM.

Authors:  E S Horton
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

Review 2.  Thiazolidinediones in the treatment of insulin resistance and type II diabetes.

Authors:  A R Saltiel; J M Olefsky
Journal:  Diabetes       Date:  1996-12       Impact factor: 9.461

3.  Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus.

Authors:  S P Helmrich; D R Ragland; R W Leung; R S Paffenbarger
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

4.  Standardization of enzyme assays.

Authors:  H U Bergmeyer
Journal:  Clin Chem       Date:  1972-11       Impact factor: 8.327

5.  A new useful modification for the determination of gamma-glutamyltranspeptidase activity.

Authors:  V Kulhánek; D M Dimov
Journal:  Clin Chim Acta       Date:  1966-11       Impact factor: 3.786

6.  Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

Authors:  Vinod Mattoo; David Eckland; Mario Widel; Santiago Duran; Carmen Fajardo; Jorma Strand; Debbie Knight; Loren Grossman; David Oakley; Meng Tan
Journal:  Clin Ther       Date:  2005-05       Impact factor: 3.393

Review 7.  Biguanides and NIDDM.

Authors:  C J Bailey
Journal:  Diabetes Care       Date:  1992-06       Impact factor: 19.112

8.  High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study.

Authors:  J A Marshall; R F Hamman; J Baxter
Journal:  Am J Epidemiol       Date:  1991-09-15       Impact factor: 4.897

Review 9.  Dietary therapy in diabetes mellitus. Is there a single best diet?

Authors:  S M Grundy
Journal:  Diabetes Care       Date:  1991-09       Impact factor: 19.112

10.  Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

Authors:  Giuseppe Derosa; Arrigo F G Cicero; Antonio Gaddi; Pietro D Ragonesi; Elena Fogari; Gianandrea Bertone; Leonardina Ciccarelli; Mario N Piccinni
Journal:  Clin Ther       Date:  2004-05       Impact factor: 3.393

View more
  2 in total

1.  Effects of insulin, glimepiride and combination therapy of insulin and metformin on blood sugar and lipid profile of NIDDM patients.

Authors:  Sona Valsaraj; K T Augusti; Varghese Chemmanam; Regi Jose
Journal:  Indian J Clin Biochem       Date:  2009-07-09

2.  A study on the hypoglycemic and hypolipidemic effects of an ayurvedic drug Rajanyamalakadi in diabetic patients.

Authors:  P Faizal; S Suresh; R Satheesh Kumar; K T Augusti
Journal:  Indian J Clin Biochem       Date:  2009-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.